Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Solid Biosciences Inc’s stock clocked out at $5.29, down -0.38% from its previous closing price of $5.31. In other words, the price has decreased by -$0.38 from its previous closing price. On the day, 0.65 million shares were traded. SLDB stock price reached its highest trading level at $5.497 during the session, while it also had its lowest trading level at $5.17.
Ratios:
To gain a deeper understanding of SLDB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.74 and its Current Ratio is at 6.74. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In the most recent recommendation for this company, Needham on December 04, 2025, initiated with a Buy rating and assigned the stock a target price of $16.
On June 26, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $14.
On January 08, 2025, Truist started tracking the stock assigning a Buy rating and target price of $16.Truist initiated its Buy rating on January 08, 2025, with a $16 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 05 ’26 when Ganot Ilan sold 1,053 shares for $5.43 per share. The transaction valued at 5,718 led to the insider holds 17,278 shares of the business.
Howton David T sold 4,932 shares of SLDB for $25,203 on Dec 03 ’25. The Chief Operating Officer now owns 32,908 shares after completing the transaction at $5.11 per share. On Dec 03 ’25, another insider, Cumbo Alexander, who serves as the President and CEO of the company, sold 10,808 shares for $5.11 each. As a result, the insider received 55,229 and left with 81,388 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLDB now has a Market Capitalization of 412145152 and an Enterprise Value of 197940160.
Stock Price History:
The Beta on a monthly basis for SLDB is 2.67, which has changed by 0.5981873 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, SLDB has reached a high of $7.37, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is 1.42%, while the 200-Day Moving Average is calculated to be 6.94%.
Shares Statistics:
It appears that SLDB traded 1.02M shares on average per day over the past three months and 881350 shares per day over the past ten days. A total of 77.88M shares are outstanding, with a floating share count of 58.88M. Insiders hold about 24.42% of the company’s shares, while institutions hold 82.83% stake in the company. Shares short for SLDB as of 1765756800 were 9943886 with a Short Ratio of 9.79, compared to 1763078400 on 9552193. Therefore, it implies a Short% of Shares Outstanding of 9943886 and a Short% of Float of 15.17.
Earnings Estimates
Its stock is currently analyzed by 13.0 different market analysts. The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.39 and low estimates of -$0.66.
Analysts are recommending an EPS of between -$1.84 and -$2.93 for the fiscal current year, implying an average EPS of -$2.11. EPS for the following year is -$2.01, with 12.0 analysts recommending between -$1.49 and -$2.85.
